Abstract Background Transcatheter aortic valve implantation (TAVI) has emerged as an effective and safe treatment for patients with symptomatic aortic stenosis. The indication to TAVI should be agreed upon by..
Read More
Abstract Since its approval by the Food and Drug Administration in 2011, transcatheter aortic valve implantation (TAVI) has rapidly evolved to become the preferred ultimate intervention for high- and intermediate-risk..
Read More
Abstract Valve-in-valve (ViV) (ViV-TAVI) with failed bioprostheses arose as an alternative to redo surgical (SAVR). To evaluate all-cause mortality in ViV-TAVI versus redo-SAVR, we performed a study-level meta-analysis of reconstructed time-to-event data from..
Read More
Abstract Summary The retrograde valve-crossing of a stenotic aortic valve is a crucial step in the transcatheter aortic valve implantation procedure. In addition to being time-consuming and associated with..
Read More
Backup perfusion coverage for TAVR is a standard of care in the United States. The panel explores other centers in Europe that does not provide any backup coverage and discusses..
Read More
Abstract (IE) after (TAVI) and surgical (SAVR) is a rare but life-threatening complication. Paravalvular regurgitation, compression of native leaflets, and space between transcatheter and native valves could dispose recipients at increased risk of IE..
Read More
Abstract Objectives To analyse the effect of the implementation of a transcatheter aortic valve replacement (TAVR) and multidisciplinary heart team programme on mortality in severe aortic stenosis (AS). Methods A retrospective, observational..
Read More